Clinical Trial Update: A Microneurography Study of NaV1.8 Inhibition in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 microneurography study in healthy adults evaluating Nav1.8 inhibition for pain has completed, providing early mechanistic data on this approach.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Nav1.8 inhibitor (experimental)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Pain | Phase 1 | Status: COMPLETED